Retour
Fourchette du Jour
15,01 €
16,10 €
Fourchette 52 Semaines
7,76 €
71,50 €
Volume
1 766 376
Moyenne 50J / 200J
20,69 €
/
25,16 €
Clôture Précédente
15,92 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -4,7 | 0,4 |
| P/B | 4,7 | 2,9 |
| ROE % | -207,1 | 3,7 |
| Net Margin % | -1236,0 | 3,9 |
| Rev Growth 5Y % | -58,1 | 10,0 |
| D/E | 2,7 | 0,2 |
Objectif de Cours des Analystes
Hold
41,80 €
+175.4%
Low: 11,00 €
High: 95,00 €
BPA Prévisionnel
-3,49 €
CA Est.
32 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,52 €
0,37 € – 3,90 €
|
580 M | 5 |
| FY2029 |
-0,56 €
-1,44 € – -0,14 €
|
370 M | 2 |
| FY2028 |
-2,61 €
-4,42 € – 1,21 €
|
180 M | 7 |
Points Clés
Revenue declined -58,13% annually over 5 years
Debt/Equity of 2,70 — high leverage
Negative free cash flow of -177,96M
PEG of 0,23 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 17,49%
Capital efficient — spends only 2,73% of revenue on capex
Croissance
Revenue Growth (5Y)
-58,13%
Revenue (1Y)-40,64%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-207,10%
ROIC-18,91%
Net Margin-1236,00%
Op. Margin-1152,13%
Sécurité
Debt / Equity
2,70
Current Ratio10,43
Interest Coverage-2,99
Valorisation
P/E Ratio
-4,70
P/B Ratio4,70
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -40,64% | Revenue Growth (3Y) | 0,80% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -58,13% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 16,10M | Net Income (TTM) | -198,97M |
| ROE | -207,10% | ROA | -24,12% |
| Gross Margin | -2,16% | Operating Margin | -1152,13% |
| Net Margin | -1236,00% | Free Cash Flow (TTM) | -177,96M |
| ROIC | -18,91% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2,70 | Current Ratio | 10,43 |
| Interest Coverage | -2,99 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -4,70 | P/B Ratio | 4,70 |
| P/S Ratio | 58,09 | PEG Ratio | 0,23 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 935,15M | Enterprise Value | 1,39B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 16,10M | 27,12M | 15,84M | 106,48M | 524,00M |
| Net Income | -198,97M | -239,56M | -308,48M | -126,79M | 329,59M |
| EPS (Diluted) | -3,46 | -4,92 | -6,47 | -2,71 | 7,04 |
| Gross Profit | -347 000,0 | 8,79M | 2,22M | 103,14M | 499,03M |
| Operating Income | -185,47M | -184,29M | -282,87M | -143,16M | 310,62M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 824,91M | 556,54M | 831,69M | 704,96M | 809,18M |
| Total Liabilities | 626,01M | 563,29M | 624,02M | 228,96M | 213,40M |
| Shareholders' Equity | 198,90M | -6,75M | 207,67M | 476,01M | 595,78M |
| Total Debt | 536,59M | 66,06M | 138,41M | 142,89M | 135,72M |
| Cash & Equivalents | 80,24M | 158,93M | 241,36M | 228,01M | 556,26M |
| Current Assets | 655,99M | 390,29M | 651,85M | 476,77M | 628,24M |
| Current Liabilities | 62,92M | 40,05M | 73,68M | 75,92M | 36,76M |